Compounds and compositions for the treatment of cancer
US9114118B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Oct 26, 2011 |
| Grant date | Aug 25, 2015 |
| Priority date | — |
| Expiry date | Oct 26, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C323/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
New uses for phenylketone carboxylate compounds and substituted aromatic compounds of Formula I, Formula I.1, Formula I.2, Formula IA, Formula IB, Formula IC and Formula II and their pharmaceutical acceptable salts for the treatment of cancer. The use of a combination of two of these compounds is described and the use of the combination of one of these compounds with an anticancer agent such as decarbazine, doxorubicin, daunorubicin, cyclophosphamide, busulfex, busulfan, vinblastine, vincristine, bleomycin, etoposide, topotecan, irinotecan, taxotere, taxol, 5-fluorouracil, methotrexate, gemcitabine, cisplatin, carboplatin and chlorambucil.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.